Govt levies import restriction on potassium clavulanate till Nov 2026
This story was originally published at 19:01 IST on 17 December 2025
Register to read our real-time news.Informist, Wednesday, Dec. 17, 2025
NEW DELHI – The government has imposed restrictions on the import of potassium clavulanate and some intermediates used for the manufacturing of clavulanic acid and potassium clavulanate, the Directorate General of Foreign Trade said Wednesday. Potassium clavulanate is primarily used by the pharmaceutical industry in manufacturing of drugs for treatment of bacterial infections.
The restriction will stay in place till Nov. 30, 2026, according to the notification. Import of potassium clavulanate with cost insurance freight value below $180 per kilogram will be restricted. For the import of diluted potassium clavulanate, cost insurance freight value must be over $77 per kg, the notification said.
Some intermediates, like tertiary butylamine salt and tertiary octylamine salt, used in manufacturing of clavulanic acid and potassium clavulanate, can be imported only if cost insurance freight value exceeds $92 per kg. End
US$1 = INR 90.38
Reported by Krity Ambey
Edited by Tanima Banerjee
For users of real-time market data terminals, Informist news is available exclusively on the NSE Cogencis WorkStation.
Cogencis news is now Informist news. This follows the acquisition of Cogencis Information Services Ltd. by NSE Data & Analytics Ltd., a 100% subsidiary of the National Stock Exchange of India Ltd. As a part of the transaction, the news department of Cogencis has been sold to Informist Media Pvt. Ltd.
Informist Media Tel +91 (22) 6985-4000
Send comments to feedback@informistmedia.com
© Informist Media Pvt. Ltd. 2025. All rights reserved.
To read more please subscribe
Share this Story:
